DCM
ACOR

Dupont Capital Management’s Acorda Therapeutics ACOR Stock Holding History

Dupont Capital Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-821
Closed -$283K – 1310
2019
Q3 		$283K Buy
821
+423
+106% +$230K 0.01% 1022
2019
Q2 		$366K Buy
398
+222
+126% +$273K 0.01% 920
2019
Q1 		$280K Buy
+176
New +$317K 0.01% 974
2017
Q4 		– Sell
-283
Closed -$804K – 1006
2017
Q3 		$804K Hold
283
– – 0.02% 573
2017
Q2 		$670K Sell
283
-310
-52% -$614K 0.01% 610
2017
Q1 		$1.5M Buy
+593
New +$1.71M 0.03% 416
2016
Q3 		– Sell
-240
Closed -$736K – 719
2016
Q2 		$736K Buy
240
+92
+62% +$299K 0.02% 513
2016
Q1 		$471K Hold
148
– – 0.01% 551
2015
Q4 		$762K Sell
148
-100
-40% -$437K 0.02% 520
2015
Q3 		$788K Buy
248
+36
+17% +$140K 0.02% 485
2015
Q2 		$846K Hold
212
– – 0.02% 457
2015
Q1 		$845K Sell
212
-53
-20% -$243K 0.02% 464
2014
Q4 		$1.3M Sell
265
-96
-27% -$412K 0.02% 433
2014
Q3 		$1.47M Hold
361
– – 0.03% 386
2014
Q2 		$1.46M Sell
361
-109
-23% -$444K 0.02% 427
2014
Q1 		$2.14M Hold
470
– – 0.03% 359
2013
Q4 		$1.65M Sell
470
-73
-13% -$285K 0.03% 402
2013
Q3 		$2.23M Sell
543
-80
-13% -$345K 0.04% 349
2013
Q2 		$2.47M Buy
+623
New +$2.57M 0.05% 328

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dupont Capital Management's ACOR Position: Q4 2019 in Review

Dupont Capital Management sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 821 shares — an estimated $283K sold.

Dupont Capital Management first reported a position in ACOR in Q2 2013 and held it in 19 quarters. The position peaked at $2.47M in Q2 2013. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Dupont Capital Management reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Dupont Capital Management sold 821 Acorda Therapeutics shares in Q4 2019, an estimated $283K.
  • Dupont Capital Management first reported a position in Acorda Therapeutics in Q2 2013 and held it in 19 quarters.
  • Dupont Capital Management's Acorda Therapeutics position peaked at $2.47M in Q2 2013.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Dupont Capital Management's 13F filing for Q4 2019, filed 27 Jan 2020.